alexa Design, Synthesis And Pharmacological Profiling Of Dual Modulators Of Soluble Epoxide Hydrolase And Peroxisome Proliferator Activated Rezeptors
ISSN: 2161-0444

Medicinal chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

3rd International Conference on Medicinal Chemistry & Computer Aided Drug Designing
December 08-10, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Ren? Bl?cher, Sandra Wittmann, Christina Lamers, Julia Weber, Astrid Kahnt, Marcel Boss, Astrid Br?ggerhoff, Mario Wurglics, Astrid Kaiser, Lilia Weizel, Bernhard Br?ne, Dieter Steinhilber, Manfred Schubert-Zsilavecz and Ewgenij Proschak
Posters: Med Chem
DOI: 10.4172/2161-0444.S1.012
The basic idea of this study comprehends the development of polypharmacological agents for the treatment of the metabolic syndrome. Several dual modulators of the peroxisome proliferatior-activated receptors (PPARs) and the soluble epoxide hydrolase (sEH) have been rationally designed, synthesized and pharmacologically profiled. It was possible to generate a number of active compounds containing the common pharmacophores of both targets (sEH/PPAR). The potency of sEH inhibition, determined in an in vitro assay with recombinant enzyme, is located in a sub micromolar range. The ability of the PPAR activation was evaluated in a cell-based reporter-gene assay. At a micromolar concentration, relative activations could be demonstrated, ranging from full agonists to partial modulators. The compounds activated PPAR in a subtype-selective as well as in a nonselective way. The lead compound showed no cytotoxic effect up to 30 μM in HepG2 cells. Water solubility was observed up to 500 μM in PBS buffer at pH 7.4 with 5 % of DMSO. The initiation of adipocyte differentiation was shown in human adipocytes and murine fibroblasts. An in vivo exposure study in mice presented reasonable pharmacokinetic parameters. Future in vivo studies in diabetic mouse models will show the value of this approach for the therapy of metabolic syndrome-related diseases.
image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version